Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Satellos Bioscience Inc. (MSCLF) had Non-Operating Income/Expense of $-0.21M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-20.51M |
|
-- |
|
-- |
|
$20.29M |
|
$-20.29M |
|
|
Non-Operating Income/Expense |
$-0.21M |
$-20.51M |
|
$-17.62M |
|
$-20.51M |
|
$-20.51M |
|
$-20.51M |
|
$-17.62M |
|
$-20.29M |
|
$-17.39M |
|
114.78M |
|
114.78M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$53.28M |
|
$0.00M |
|
$0.00M |
|
$53.29M |
|
$3.76M |
|
-- |
|
-- |
|
$3.76M |
|
$49.53M |
|
$49.53M |
|
$49.53M |
|
165.82M |
|
| Cash Flow Statement Financials | |
$-18.23M |
|
$4.63M |
|
$39.03M |
|
$16.10M |
|
$42.08M |
|
$25.98M |
|
$1.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.41% |
|
-41.41% |
|
-38.48% |
|
-41.41% |
|
$0.30 |
|
$-0.16 |
|
$-0.16 |
|